MediPoint: Cardiac Markers Rapid Tests and Point of Care – Global Analysis and Market Forecasts Summary Point-of-care testing (POCT), also known as bedside testing, near-patient testing, or decentralized laboratory testing, is an emerging specialty within in vitro diagnostics (IVD). POCT is one of the most rapidly growing areas in IVD, both due to the drive to increase efficiency and therefore improve patient care, and as a result of significant technological advances. This report focuses on the POC diagnostics market in the 15 major markets (15MM: US, France, Germany, Italy, Spain, UK, Japan, China, India, Brazil, Canada, Mexico, Russia, South Korea, and Australia). In this report, GlobalData evaluates the currently marketed POC products, identifies the unmet needs in each market, analyzes market dynamics, and provides an understanding of physicians’ adoption trends for different types of POC products. In order to successfully take advantage of the growing POC diagnostics market, manufacturers are required to adopt strategies that address the current unmet needs, and to concentrate on demonstrating the clinical value of their products, to drive physician adoption.
Highlights Key Questions Answered – What is the current and future cardiac marker POCT market outlook in the developed and emerging markets? What trends are affecting the global market? – What is the competitive landscape and market share of major players in the cardiac marker POCT space across different regions? – What are the key, high growth markets that IVD manufacturers should expand into? Which market segments are growing the fastest? – What are the unmet needs with the cardiac marker POC tests currently on the market? – What are the key factors influencing a physician to use cardiac marker POC tests? What is physician perception and market outlook of these devices? – What are the challenges and barriers that have hindered widespread adoption of cardiac marker POC devices?
Check Discount For This Report http://www.orbisresearch.com/contacts/discount/228239 .
Scope – Competitive assessment: Currently marketed cardiac marker POC products and evolving competitive landscape – In-depth analysis of unmet needs and adoption trends of different cardiac marker POC devices – Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications – Pipeline analysis: Emerging products and technologies. – Annualized total cardiac marker POCT market revenue by segment and market outlooks by country from 2013-2022. – Other key topics covered include strategic competitive assessment, market characterization, identification of unmet needs, market dynamics, and implications of the emerging technologies on the market.
Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/228239 .
Reasons to buy The report will enable you to – – Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline – Develop business strategies by understanding the trends shaping and driving the global market – Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global market in the future – Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors – Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage – Track device sales in the global market from 2014-2023 – Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships Companies Mentioned: Abbott Point of Care Alere LSI Medience Philips Healthcare Radiometer Medical Response Biomedical Roche Diagnostics Siemens Healthineers Trinity Biotech
For more information contact firstname.lastname@example.org
Some Points From List of Table
Table 1: Advantages and Disadvantages of POCT 16
Table 2: Regulatory Issues and Recalls 2012-2016 36
Table 3: Mergers, Acquisitions, and Key Partnerships, 2015-2016 38
Table 4: Company Profile – Abbott Point of Care 43
Table 5: Abbott Point of Care Portfolio Assessment, 2016 44
Table 6: SWOT Analysis – Abbott Point of Care 44
Table 7: Company Profile – Alere 45
Table 8: Alere POC Portfolio Assessment, 2016 46
Table 9: SWOT Analysis – Alere 47
Table 10: Company Profile – LSI Medience 48
Table 11: LSI Medience POC Portfolio Assessment, 2016 49
Table 12: SWOT Analysis – LSI Medience 50
Table 13: Company Profile – Philips Healthcare 51
Table 14: Philips Healthcare POC Portfolio Assessment, 2016 51
Table 15: SWOT Analysis – Philips Healthcare 52
Table 16: Company Profile – Radiometer Medical 53
Table 17: Radiometer Medical POC Portfolio Assessment, 2016 54
Table 18: SWOT Analysis – Radiometer Medical 54
Table 19: Company Profile – Response Biomedical 56
Table 20: Response Biomedical POC Portfolio Assessment, 2016 56
Table 21: SWOT Analysis – Response Biomedical 57
Table 22: Company Profile – Roche Diagnostics 58
Table 23: Roche Diagnostics POC Portfolio Assessment, 2016 59
Table 24: SWOT Analysis – Roche Diagnostics 59
Table 25: Company Profile – Siemens Healthineers 60
Table 26: Siemens Healthineers POC Portfolio Assessment, 2016 61
Table 27: SWOT Analysis – Siemens Healthineers 62
Table 28: Company Profile – Trinity Biotech 63
Table 29: Trinity Biotech POC Portfolio Assessment, 2016 64
Table 30: SWOT Analysis – Trinity Biotech 64
Table 31: Key Troponin POCT Pipelines, 2016 66
Table 32: Key BNP POCT Pipelines, 2016 67
Table 33: Key Cardiac Panel POCT Pipelines, 2016 68
Table 34: Key Other Cardiac Marker POCT Pipelines, 2016 69
Table 35: Troponin POCT Volume (thousands) Forecast by Country, 2014-2023 72
Table 36: BNP POCT Volume (thousands) Forecast by Country, 2014-2023 74
Table 37: Other Cardiac Marker POCT Volume (thousands) Forecast by Country, 2014-2023 75
Table 38: Global Cardiac Marker POCT Sales Forecast ($m) by Market Segment, 2014-2023
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/228239 .
For any enquires before buying, connect with us @ email@example.com